Biology of Blood and Marrow Transplantation
Volume 13, Issue 1 , Pages 74-81 , January 2007

Treatment of Adenovirus Disease in Stem Cell Transplant Recipients with Cidofovir

  • Dionissios Neofytos

      Affiliations

    • Division of Infectious Diseases and Environment Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania
    • Corresponding Author InformationCorrespondence and reprint requests: Dionissios Neofytos, MD, Division of Infectious Diseases and Environmental Medicine, Thomas Jefferson University, 125 South 9th street, Suite 403, Philadelphia, PA 19107.
    • ,
  • Ambrish Ojha

      Affiliations

    • Division of Infectious Diseases and Environment Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania
    • ,
  • Bijoyesh Mookerjee

      Affiliations

    • Division of Medical Oncology, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania
    • ,
  • John Wagner

      Affiliations

    • Division of Medical Oncology, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania
    • ,
  • Joanne Filicko

      Affiliations

    • Division of Medical Oncology, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania
    • ,
  • Andres Ferber

      Affiliations

    • Division of Medical Oncology, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania
    • ,
  • Scott Dessain

      Affiliations

    • Division of Medical Oncology, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania
    • ,
  • Dolores Grosso

      Affiliations

    • Division of Medical Oncology, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania
    • ,
  • Janet Brunner

      Affiliations

    • Division of Medical Oncology, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania
    • ,
  • Neal Flomenberg

      Affiliations

    • Division of Medical Oncology, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania
    • ,
  • Phyllis Flomenberg

      Affiliations

    • Division of Infectious Diseases and Environment Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania

Received 10 July 2006 ,Accepted 28 August 2006.

References 

  1. Bruno B, Gooley T, Hackman RC, Davis C, Corey L, Boeckh M. Adenovirus infection in hematopoietic stem cell transplantation: effect of ganciclovir and impact on survival. Biol Blood Marrow Transplant. 2003;9:341–352
  2. Flomenberg P, Babbitt J, Drobyski WR, et al. Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis. 1994;169:775–781
  3. Lion T, Baumgartinger R, Watzinger F, et al. Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood. 2003;102:1114–1120
  4. Shields AF, Hackman RC, Fife KH, Corey L, Meyers JD. Adenovirus infections in patients undergoing bone-marrow transplantation. N Engl J Med. 1985;312:529–533
  5. Howard DS, Phillips GL, Reece DE, et al. Adenovirus infections in hematopoietic stem cell transplant recipients. Clin Infect Dis. 1999;29:1494–1501
  6. Baldwin A, Kingman H, Darville M, et al. Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation. Bone Marrow Transplant. 2000;26:1333–1338
  7. Suparno C, Milligan DW, Moss PA, Mautner V. Adenovirus infections in stem cell transplant recipients: recent developments in understanding of pathogenesis, diagnosis and management. Leuk Lymphoma. 2004;45:873–885
  8. La Rosa AM, Champlin RE, Mirza N, et al. Adenovirus infections in adult recipients of blood and marrow transplants. Clin Infect Dis. 2001;32:871–876
  9. Bordigoni P, Carret AS, Venard V, Witz F, Le Faou A. Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis. 2001;32:1290–1297
  10. de Oliveira CB, Stevenson D, LaBree L, McDonnell PJ, Trousdale MD. Evaluation of cidofovir (HPMPC, GS-504) against adenovirus type 5 infection in vitro and in a New Zealand rabbit ocular model. Antiviral Res. 1996;31:165–172
  11. Legrand F, Berrebi D, Houhou N, et al. Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children. Bone Marrow Transplant. 2001;27:621–626
  12. Hoffman JA, Shah AJ, Ross LA, Kapoor N. Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2001;7:388–394
  13. Ljungman P, Ribaud P, Eyrich M, et al. Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2003;31:481–486
  14. Leruez-Ville M, Minard V, Lacaille F, et al. Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection. Clin Infect Dis. 2004;38:45–52
  15. Blazar BR, Thiele DL, Vallera DA. Pretreatment of murine donor grafts with L-leucyl-L-leucine methyl ester: elimination of graft-versus-host disease without detrimental effects on engraftment. Blood. 1990;75:798–805
  16. Thiele DL, Lipsky PE. Mechanism of L-leucyl-L-leucine methyl ester-mediated killing of cytotoxic lymphocytes: dependence on a lysosomal thiol protease, dipeptidyl peptidase I, that is enriched in these cells. Proc Natl Acad Sci U S A. 1990;87:83–87
  17. Blanke C, Clark C, Broun ER, et al. Evolving pathogens in allogeneic bone marrow transplantation: increased fatal adenoviral infections. Am J Med. 1995;99:326–328
  18. Echavarria M, Forman M, van Tol MJ, Vossen JM, Charache P, Kroes AC. Prediction of severe disseminated adenovirus infection by serum PCR. Lancet. 2001;358(9279):384–385
  19. Claas EC, Schilham MW, de Brouwer CS, et al. Internally controlled real-time PCR monitoring of adenovirus DNA load in serum or plasma of transplant recipients. J Clin Microbiol. 2005;43:1738–1744
  20. Ribaud P, Scieux C, Freymuth F, Morinet F, Gluckman E. Successful treatment of adenovirus disease with intravenous cidofovir in an unrelated stem-cell transplant recipient. Clin Infect Dis. 1999;28:690–691
  21. Muller WJ, Levin MJ, Shin YK, et al. Clinical and in vitro evaluation of cidofovir for treatment of adenovirus infection in pediatric hematopoietic stem cell transplant recipients. Clin Infect Dis. 2005;41:1812–1816
  22. Kampmann B, Cubitt D, Walls T, et al. Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation. Br J Haematol. 2005;130:595–603
  23. Hartline CB, Gustin KM, Wan WB, et al. Ether lipid-ester prodrugs of acyclic nucleoside phosphonates: activity against adenovirus replication in vitro. J Infect Dis. 2005;191:396–399
  24. Heemskerk B, Lankester AC, van Vreeswijk T, et al. Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients. J Infect Dis. 2005;191:520–530
  25. Chakrabarti S, Mautner V, Osman H, et al. Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood. 2002;100:1619–1627

PII: S1083-8791(06)00600-8

doi: 10.1016/j.bbmt.2006.08.040

Biology of Blood and Marrow Transplantation
Volume 13, Issue 1 , Pages 74-81 , January 2007

Article Tools

* Image Usage & Resolution